Seeking Alpha

  Alnylam Pharmaceuticals, Inc. - NASDAQ

10/30/2014, 3:08 PM ET
  • Jim Van Meerten | Send Message 4 Jan 2012

    ALNY - 96% Barchart technical buy signal - 15 new highs and up 27.02% in the last month - Relative Strength Index 68.01%
      ALNY vs. ETF Alternatives
      Company Description
      Alnylam Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States